top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jesse is a seasoned leader in the biopharmaceutical development field with over two decades of experience at companies like Lonza, Cytovance Biologics, Mascoma, Clean Harbors, and Wheeler Bio. With a robust background spanning both private and public enterprises, he has successfully navigated P&L responsibilities and client-facing roles while showcasing versatile leadership across multiple domains including innovation, development, manufacturing, supply chain, quality assurance, regulatory affairs, finance, and commercial operations. During his tenure as Chief Technology Officer at Cytovance Biologics in Oklahoma City, Jesse played a crucial role in driving remarkable growth, tripling the company's top-line revenue over five years and significantly boosting EBITDA by expanding commercial manufacturing capabilities. His leadership as CEO was instrumental in guiding Cytovance through a successful IPO in 2020, raising $585 million USD for the parent company. Following his impactful seven-year journey at Cytovance, Jesse ventured into entrepreneurial endeavors as an entrepreneur-in-residence at Echo Investment Capital. Here, he co-founded Wheeler Bio in 2021, focusing on clinical-scale manufacturing, a testament to his commitment to advancing the industry. Jesse is a scientist by training, holding a Ph.D. in Microbiology from the University of Massachusetts, complemented by postdoctoral work at Dartmouth. His work in academia includes making contributions to over 25 peer-reviewed journal articles and book chapters, alongside being a sought-after presenter at industry conferences. Despite being a New England native, Jesse has made Oklahoma his home since 2013, where he resides with his family.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers

Jens H. Vogel

President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt

Global R&D Director Cell & Gene Therapies Portfolio at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Behzad Mahdavi

CEO & Board member at InnoGI Technologies & Executive Chairman at Open Cell Technologies

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS
bottom of page